RU2012152800A - HYDROXYALKYLBENZYLPYRAZOLES AND THEIR APPLICATION FOR TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES - Google Patents
HYDROXYALKYLBENZYLPYRAZOLES AND THEIR APPLICATION FOR TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES Download PDFInfo
- Publication number
- RU2012152800A RU2012152800A RU2012152800/04A RU2012152800A RU2012152800A RU 2012152800 A RU2012152800 A RU 2012152800A RU 2012152800/04 A RU2012152800/04 A RU 2012152800/04A RU 2012152800 A RU2012152800 A RU 2012152800A RU 2012152800 A RU2012152800 A RU 2012152800A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- diyl
- compound
- methyl
- group
- Prior art date
Links
- 0 CCC[C@@](C)(*)N Chemical compound CCC[C@@](C)(*)N 0.000 description 2
- FNORAMJWDGTTIW-UHFFFAOYSA-N CC1=CC(C(O)=O)=NCC11NC1 Chemical compound CC1=CC(C(O)=O)=NCC11NC1 FNORAMJWDGTTIW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Соединение формулы (I):,в которойA означает группу формулы:или,в которой* означает место соединения с гидроксильной группой,** означает место соединения с фенильным кольцом,Rи Rнезависимо друг от друга означают водород, дейтерий, метил, гидроксиметил или трифторметил, илиRи Rсоединены друг с другом и совместно с атомом углерода, к которому они присоединены, образуют циклопропан-1,1-диильное, циклобутан-1,1-диильное, оксетан-3,3-диильное или тетрагидро-2Н-пиран-4,4-диильное кольцо,Rи Rнезависимо друг от друга означают водород, дейтерий, метил или трифторметил,Rи Rнезависимо друг от друга означают водород, фтор, метил, гидроксиметил или трифторметил, илиRи Rсоединены друг с другом и совместно с атомом углерода, к которому они присоединены, образуют циклопропан-1,1-диильное, циклобутан-1,1-диильное, оксетан-3,3-диильное или тетрагидро-2Н-пиран-4,4-диильное кольцо,Rозначает трифторметокси, трифторметилсульфанил, трифторметилсульфонил, пентафторсульфанил, триметилсилил или группу формулы, в которой# обозначает место соединения с фенильным кольцом,Rи Rнезависимо друг от друга означают водород, фтор, метил, этил, н-пропил или изопропил, илиRи Rсоединены друг с другом и совместно с атомом углерода, к которому они присоединены, образуют циклопропан-1,1-диильное, циклобутан-1,1-диильное, циклопентан-1,1-диильное, циклогексан-1,1-диильное, оксетан-3,3-диильное или тетрагидро-2Н-пиран-4,4-диильное кольцо, иRозначает водород, фтор, метил, трифторметил, метоксиметил или этоксиметил,иRозначает водород, фтор или метил,а также их соли, сольваты и сольваты солей.2. Соединение формулы (I) по п.1, в которойA означает группу формулы:,,,,,или,в которой* означает место 1. The compound of formula (I):, in which A represents a group of the formula: or, in which * means a compound with a hydroxyl group, ** means a compound with a phenyl ring, R and R are independently hydrogen, deuterium, methyl, hydroxymethyl or trifluoromethyl, or R and R are connected to each other and together with the carbon atom to which they are attached form cyclopropane-1,1-diyl, cyclobutane-1,1-diyl, oxetane-3,3-diyl or tetrahydro-2H-pyran-4 The 4-diyl ring, R and R are independently hydrogen, deuterium, methyl or three. tormethyl, R and R independently of one another mean hydrogen, fluorine, methyl, hydroxymethyl or trifluoromethyl, or R and R are connected to each other and together with the carbon atom to which they are attached form cyclopropane-1,1-diyl, cyclobutane-1,1-diyl , oxetane-3,3-diyl or tetrahydro-2H-pyran-4,4-diyl ring, R is trifluoromethoxy, trifluoromethylsulfanyl, trifluoromethylsulfonyl, pentafluorosulfanyl, trimethylsilyl or a group of the formula in which # denotes the place of connection with the phenyl ring, independently friend's mean hydrogen, ft op, methyl, ethyl, n-propyl or isopropyl, or R and R are connected to each other and together with the carbon atom to which they are attached form cyclopropane-1,1-diyl, cyclobutane-1,1-diyl, cyclopentane-1,1 -diyl, cyclohexane-1,1-diyl, oxetane-3,3-diyl or tetrahydro-2H-pyran-4,4-diyl ring, and R is hydrogen, fluoro, methyl, trifluoromethyl, methoxymethyl or ethoxymethyl, and R is hydrogen, fluoro or methyl, as well as their salts, solvates and solvates of salts. 2. The compound of formula (I) according to claim 1, in which A means a group of the formula: ,,,,, or, in which * means a place
Claims (17)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10004854 | 2010-05-08 | ||
EP10004854.5 | 2010-05-08 | ||
PCT/EP2011/057019 WO2011141325A1 (en) | 2010-05-08 | 2011-05-03 | Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012152800A true RU2012152800A (en) | 2014-06-20 |
Family
ID=44243203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012152800/04A RU2012152800A (en) | 2010-05-08 | 2011-05-03 | HYDROXYALKYLBENZYLPYRAZOLES AND THEIR APPLICATION FOR TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2569309A1 (en) |
JP (1) | JP2013530139A (en) |
KR (1) | KR20130108998A (en) |
CN (1) | CN103003266A (en) |
AU (1) | AU2011252222A1 (en) |
BR (1) | BR112012028652A2 (en) |
CA (1) | CA2798374A1 (en) |
IL (1) | IL222850A0 (en) |
MX (1) | MX2012012905A (en) |
RU (1) | RU2012152800A (en) |
WO (1) | WO2011141325A1 (en) |
ZA (1) | ZA201209298B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2888256A4 (en) * | 2012-08-24 | 2016-02-17 | Univ Texas | Heterocyclic modulators of hif activity for treatment of disease |
NZ704799A (en) | 2012-08-24 | 2018-06-29 | Univ Texas | Heterocyclic modulators of hif activity for treatment of disease |
EP2888253A4 (en) | 2012-08-24 | 2016-01-06 | Univ Texas | Heterocyclic modulators of hif activity for treatment of disease |
ES2726648T3 (en) | 2014-02-25 | 2019-10-08 | Univ Texas | Salts of heterocyclic modulators of HIF activity for the treatment of diseases |
CN107235873B (en) * | 2017-07-04 | 2018-11-06 | 中节能万润股份有限公司 | A kind of preparation method of mesna |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004228057A1 (en) | 2003-04-03 | 2004-10-21 | Merck & Co., Inc. | Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
WO2005030121A2 (en) | 2003-06-30 | 2005-04-07 | Hif Bio, Inc. | Compounds, compositions and methods |
WO2007065010A2 (en) | 2005-12-02 | 2007-06-07 | Hif Bio, Inc. | Anti-angiogenesis compounds |
WO2008141731A2 (en) | 2007-05-18 | 2008-11-27 | Bayer Healthcare Ag | Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
EP2356113B1 (en) * | 2008-11-14 | 2015-01-07 | Bayer Intellectual Property GmbH | Heterocyclically substituted aryl compounds as hif inhibitors |
DE102008057344A1 (en) * | 2008-11-14 | 2010-05-20 | Bayer Schering Pharma Aktiengesellschaft | Aminoalkyl-substituted aryl compounds and their use |
EP2202232A1 (en) | 2008-12-26 | 2010-06-30 | Laboratorios Almirall, S.A. | 1,2,4-oxadiazole derivatives and their therapeutic use |
US8389509B2 (en) | 2009-01-23 | 2013-03-05 | Bristol-Myers Squibb Company | Substituted pyrazole compounds |
-
2011
- 2011-05-03 MX MX2012012905A patent/MX2012012905A/en unknown
- 2011-05-03 CN CN2011800338366A patent/CN103003266A/en active Pending
- 2011-05-03 BR BR112012028652A patent/BR112012028652A2/en not_active IP Right Cessation
- 2011-05-03 RU RU2012152800/04A patent/RU2012152800A/en not_active Application Discontinuation
- 2011-05-03 WO PCT/EP2011/057019 patent/WO2011141325A1/en active Application Filing
- 2011-05-03 CA CA2798374A patent/CA2798374A1/en not_active Abandoned
- 2011-05-03 KR KR1020127032070A patent/KR20130108998A/en not_active Application Discontinuation
- 2011-05-03 EP EP11716947A patent/EP2569309A1/en not_active Withdrawn
- 2011-05-03 JP JP2013509504A patent/JP2013530139A/en not_active Withdrawn
- 2011-05-03 AU AU2011252222A patent/AU2011252222A1/en not_active Abandoned
-
2012
- 2012-11-05 IL IL222850A patent/IL222850A0/en unknown
- 2012-12-07 ZA ZA2012/09298A patent/ZA201209298B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011252222A1 (en) | 2012-12-06 |
CN103003266A (en) | 2013-03-27 |
BR112012028652A2 (en) | 2016-08-09 |
ZA201209298B (en) | 2014-05-28 |
KR20130108998A (en) | 2013-10-07 |
IL222850A0 (en) | 2012-12-31 |
CA2798374A1 (en) | 2011-11-17 |
MX2012012905A (en) | 2012-12-17 |
JP2013530139A (en) | 2013-07-25 |
EP2569309A1 (en) | 2013-03-20 |
WO2011141325A1 (en) | 2011-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012152800A (en) | HYDROXYALKYLBENZYLPYRAZOLES AND THEIR APPLICATION FOR TREATMENT OF HYPERPROLIFERATIVE AND ANGIOGENIC DISEASES | |
JP2763894B2 (en) | Biologically active carboxylic esters | |
JP2018536648A5 (en) | ||
JP2016526540A5 (en) | ||
JP2019510787A5 (en) | ||
JP2018535963A5 (en) | ||
JP2012525393A5 (en) | ||
RU2012121577A (en) | SUBSTITUTED 3-PHENYL PROPIONIC ACIDS AND THEIR APPLICATION | |
JP2019524883A5 (en) | ||
JP6628252B2 (en) | Pharmaceutical composition for treatment of ischemic eye disease | |
JP2011051993A5 (en) | ||
JP2018513832A5 (en) | ||
JP2020075939A5 (en) | ||
JP2013526497A5 (en) | ||
JP2018109017A5 (en) | ||
JP2018526448A (en) | Prodrug molecules capable of releasing nitric oxide | |
JP2011519360A5 (en) | ||
JP2010540649A5 (en) | ||
JP2009538894A5 (en) | ||
HUE027711T2 (en) | Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | |
EP3129368A1 (en) | Cytotoxic compounds which are inhibitors of the polymerisation of tubulin | |
JPS6287574A (en) | Novel n-substituted 3,4-dihydropyrimidin-2-one derivative, production thereof and remedy for circulatory disease containing same | |
RU2433125C2 (en) | Substituted quinolones having antiviral activity, synthesis method thereof, medicinal agent and use thereof in fighting viral infections | |
CN105732412A (en) | Amide compound for treating stroke and preparation method thereof | |
TN2015000240A1 (en) | Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20140505 |